These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4270402)

  • 21. Porphyrin biosynthesis from ALA and PBG by human erythrocytes in porphyrin disorders. Kinetic studies of the isomer series I and III.
    Schermuly E; Doss M
    Ann Clin Res; 1976; 8 Suppl 17():92-102. PubMed ID: 1008503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Porphyrin precursors in acute porphyria.
    Eales L
    S Afr Med J; 1978 Jan; 53(3):79-80. PubMed ID: 653477
    [No Abstract]   [Full Text] [Related]  

  • 23. [Intermittent acute porphyria (author's transl)].
    Clotet B; Pérez C; Martinez-Vázquez JM
    Med Clin (Barc); 1979 Jun; 73(1):32-8. PubMed ID: 470503
    [No Abstract]   [Full Text] [Related]  

  • 24. Intermittent acute porphyria.
    Arch Intern Med; 1982 Aug; 142(8):1527-9. PubMed ID: 7103634
    [No Abstract]   [Full Text] [Related]  

  • 25. [Mechanism of delta-aminolevulinic acid neurotoxicity].
    Taljaard JJ; Lamm MC; Truter L; McCarthy BW; Percy VA; Neethling AC
    S Afr Med J; 1981 Aug; 60(5):180-3. PubMed ID: 6114570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial metabolism in porphyric rat liver.
    Miyahara M; Hirata K; Tada H; Seno S
    Biochim Biophys Acta; 1973 Oct; 325(1):47-53. PubMed ID: 4358812
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of clonidine in a primed rat model of acute hepatic porphyria.
    Goerz G; Bolsen K; Böhrer H; Fritsch C; Kalka K; Rominger KL
    Arzneimittelforschung; 1997 Jun; 47(6):731-3. PubMed ID: 9239451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The acute porphyric attack. I. The electrolyte disorder of the acute porphyric attack and the possible role of delta-aminolaevulic acid.
    Eales L; Dowdle EB; Sweeney GD
    S Afr Med J; 1971 Sep; ():89-97. PubMed ID: 5150300
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of haem arginate and haematin upon the allylisopropylacetamide induced experimental porphyria in rats.
    Tokola O; Lindén IB; Tenhunen R
    Pharmacol Toxicol; 1987 Jul; 61(1):75-8. PubMed ID: 3628186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of clinical manifestations in acute intermittent porphyria].
    Kaszewska-Jablońska I; Bielawski W; Bardzik I
    Pol Arch Med Wewn; 1973 Jun; 50(6):545-53. PubMed ID: 4732435
    [No Abstract]   [Full Text] [Related]  

  • 31. [Acute intermittent porphyria].
    Wetterberg L
    Lakartidningen; 1974 Jun; 71(24):2461-5. PubMed ID: 4599136
    [No Abstract]   [Full Text] [Related]  

  • 32. Biochemical basis and regulatory mechanisms of porphyrin synthesis.
    Neuberger A
    Proc R Soc Med; 1968 Feb; 61(2):191-3. PubMed ID: 5637834
    [No Abstract]   [Full Text] [Related]  

  • 33. Prophyrin precursors in blood, urine and cerebrospinal fluid in acute porphyria.
    Percy VA; Shanley BC
    S Afr Med J; 1977 Jul; 52(6):219-22. PubMed ID: 897913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of delta-aminolaevulinic acid, porphobilinogen and structurally related amino acids on 2-deoxy-glucose uptake in cultured neurons.
    Russell VA; Lamm MC; Taljaard JJ
    Neurochem Res; 1982 Aug; 7(8):1009-22. PubMed ID: 6128684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A possible explanation for the neurological disturbances in the porphyrias.
    Kramer S; Viljoen D; Becker D; Metz J
    S Afr Med J; 1971 Sep; ():103-7. PubMed ID: 4260810
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of iron in the pathogenesis of porphyria cutanea tarda. An in vitro model.
    Kushner JP; Lee GR; Nacht S
    J Clin Invest; 1972 Dec; 51(12):3044-51. PubMed ID: 4640947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. delta-Aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria.
    Müller WE; Snyder SH
    Ann Neurol; 1977 Oct; 2(4):340-2. PubMed ID: 214024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 17-Oxosteroid conjugates in plasma and urine of patients with acute intermittent porphyria.
    Paxton JW; Moore MR; Deattie AD; Goldberg A
    Clin Sci Mol Med; 1974 Feb; 46(2):207-22. PubMed ID: 4817273
    [No Abstract]   [Full Text] [Related]  

  • 39. Intermittent acute porphyria--demonstration of a genetic defect in porphobilinogen metabolism.
    Meyer UA; Strand LJ; Doss M; Rees AC; Marver HS
    N Engl J Med; 1972 Jun; 286(24):1277-82. PubMed ID: 5024458
    [No Abstract]   [Full Text] [Related]  

  • 40. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin.
    Bonkowsky HL; Tschudy DP; Collins A; Doherty J; Bossenmaier I; Cardinal R; Watson CJ
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2725-9. PubMed ID: 5288250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.